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Abstract—The synthesis of Fmoc protected amino acid hydroxamates using Fmoc-amino acid chlorides and magnesium oxide is
described. The method is simple and efficient, results in complete conversion, and gives good yields and satisfactory purity.
© 2003 Elsevier Science Ltd. All rights reserved.
Amino acid hydroxamates are useful as building blocks
for the synthesis of peptide hydroxamates which have
received increased attention due to their variety of
biological activities especially as antibacterial, anti-
cancer, antiasthmatic, psychotropic, antifungal and
insecticidal agents.1 As the hydroxamic acid functional-
ity is an effective metal ion chelator, compounds having
this functionality serve as potent inhibitors of metallo-
proteases.2 Hydroxamic acids have generally been syn-
thesized in solution by the acylation of O-/N-protected
hydroxylamines such as O-benzyl hydroxylamine,
N,N1,O-(tristrimethylsilyl)-hydroxylamine, N-Boc-O-
THP hydroxylamine, N-Boc-O-TBDMS-hydroxyl-
amine and O-trimethylsilylhydroxylamine with acti-
vated carboxylic acids.3 Direct acylation of hydroxyl-
amine itself is well known to result in a mixture of N-
and O-acylated as well as di- and tri-acylated prod-
ucts.4 Alternatively, acylations using peptide coupling
agents like PyBOP, TBTU, HATU, BOP, etc., need
O-protected hydroxylamine derivatives and the reaction
has to be carried out in the presence of an equimolar
quantity of an organic base such as triethylamine
(TEA), N-ethyldiisopropylamine (DIEA), 1,8-diazabi-
cyclo[5,4,0]undec-7-ene (DBU), N-methylpyrrolidone
(NMP), etc.5 On the other hand, our group has demon-
strated the advantages of base-free conditions for the
coupling of Fmoc-amino acid chlorides in the synthesis
of peptides containing adjacent Aib groups as well as
for the introduction of the Fmoc group into amino
acids.6 Thus, the use of co-coupling agents like potas-
sium salts of 1-hydroxybenzotriazole (KOBt) and 7-
aza-1-hydroxybenzotriazole (KOAt), AgCN, zinc dust,
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etc., led us to carry out acylation reactions under
non-Schotton–Baumann conditions which naturally cir-
cumvents the well identified side reactions.
Magnesium oxide (MgO) has gained some attention
because of its novel surface catalytic properties.7 Its use
in the synthesis of pyrimidine from 2,4-dichloropyrim-
idine, in the hydrogenation of 1,3-butadiene to cis-2-
butene, in the reduction of ,-unsaturated ketones to
allylic alcohols by the Meerwein–Ponndorf–Verley
method, in the dehydrogenative coupling between
hydrosilanes and mono substituted alkynes, and in the
heterogeneous Wittig, Knoevenagel, and Wittig–Horner
reactions is well documented.8
A selection of suitably N- as well as O-protected
hydroxylamine derivatives and convenient methods for
their deprotection after acylation have to be employed
as key steps in the multistep synthesis of hydroxamic
acids. In the present communication, the preparation of
O-unacylated amino acid hydroxamates directly via a
simple nucleophilic displacement is described. They
were synthesized by reacting hydroxylamine hydrochlo-
ride with Fmoc-amino acid chlorides in the presence of
MgO (Scheme 1). Hydroxylamine hydrochloride was
deprotonated using an equivalent of MgO in methanol/
water. The Fmoc-amino acid chloride, dissolved in
THF and two equivalents of MgO were then added to
the hydroxylamine solution and stirring was continued.
The reaction, as monitored by TLC and IR was com-
plete in about 20–30 min. The resulting amino acid
hydroxamates were isolated as crystalline solids in good
yield (Table 1). Their purity, as checked by analytical
RP-HPLC, was satisfactory. All the amino acid
hydroxamates were fully characterized by 1H NMR and
ES-MS. The spectroscopic analysis clearly revealed that
no traces of O-acylated or N,O-bisacylated derivatives
were present under the conditions employed.
In conclusion, Fmoc-amino acid hydroxamates can be
synthesized by the acylation of hydroxylamine using
Fmoc-amino acid chlorides in the presence of MgO.
The route is simple, efficient and affords good to excel-
lent yields of products. The 1H NMR and MS data
confirms that no O-acylation took place.
General procedure for the synthesis of Fmoc-amino acid
hydroxamates
Hydroxylamine hydrochloride (0.084 g, 1.2 mmol) in
methanol/water (3:2, 5 mL) was treated with MgO
(0.040 g, 1 mmol), then a solution of Fmoc-amino acid
chloride (1 mmol) in THF (8 mL), and MgO (0.080 g,
2 mmol) were added. The mixture was stirred at rt until
completion of the reaction, then filtered and evaporated
Table 1. Physical constants and characterization data of Fmoc-amino acid hydroxamates*
Compd 2 Yield (%) Mp (°C) Rf value IR (max., 1H NMR (, ppm)
cm−1)
1560, 1650 0.9 (t, J=6.2 Hz, 3H), 0.98 (d, J=6.2 Hz, 3H), 1.3 (m, 2H), 1.90.3417886a
(m, 1H), 3.2 (t, J=9.35 Hz, 1H), 4.25 (t, J=6.5 Hz, 1H), 4.321690, 3300
(d, J=6.5 Hz, 2H), 7.2–7.8 (m, 9H), 8.7 (br, 1H) and 10.4 (br, 1H).
90 171 0.36 1540, 1650 1.3 (d, J=7.4 Hz, 6H), 2.6 (m, 1H), 3.4 (t, J=9.3 Hz, 1H),b
4.1 (t, J=6.5 Hz, 1H), 4.3 (d, J=6.5 Hz, 2H), 7.3–7.9 (m, 9H), 8.81698, 3200
(s, 1H) and 10.6 (s, 1H).
86 0.96 (d, J=7.35 Hz, 6H), 1.65 (m, 3H), 3.8 (m, 1H), 4.18c 1540, 16400.31182
(t, J=6.5 Hz, 1H), 4.451690, 3200
(d, J=6.5 Hz, 2H), 7.2–7.8 (m, 9H), 8.6 (br, 1H) and
10.5 (br, 1H).
96 0.39 1550, 1650d 3.3 (t, J=6.5 Hz, 2H), 4.25 (t, J=6.5 Hz, 1H), 4.588
(d, J=6.5 Hz, 2H), 7.2–7.8 (m, 9H), 8.9 (br, 1H) and 10.9 (br, 1H).1700, 3300
195 0.45 1560, 1640 2.52 (m, 2H), 3.1 (m, 1H), 4.1 (t, J=6.5 Hz, 1H), 4.25e 96
1698, 3300 (d, J=6.5 Hz, 2H), 7.3–7.8 (m, 14H), 8.6 (br, 1H) and 10.62
(br, 1H).
1.45 (d, J=7.1 Hz, 3H), 3.85 (m, 1H), 4.25 (t, J=6.5 Hz, 1H), 4.41540, 16600.38f 12894
1705, 3200 (d, J=6.5 Hz, 2H), 7.3–7.9 (m, 9H), 8.55 (br, 1H) and 10.62
(br, 1H).
g 84 132 0.43 1560, 1650 3.2 (d, J=9.3 Hz, 1H), 4.1 (t, J=6.5 Hz, 1H), 4.45
1703, 3300 (d, J=6.5 Hz, 2H), 7.2–7.8 (m, 14H), 8.7 (br, 1H) and 10.4
(br, 1H).
82 92h 0.42 1540, 1660 2.2 (m, 4H), 3.5 (m, 2H), 4.1 (t, J=6.5 Hz, 1H), 4.3
(d, J=6.5 Hz, 2H), 7.2–7.8 (m, 9H), 8.45 (br, 1H) and 10.521698, 3200
(br, 1H).
85i 164 0.48 1550, 1660 3.3 (s, 2H), 3.6 (m, 2H), 4.25 (m, 3H), 4.5
1690, 3300 (m, 1H), 7.2–7.8 (m, 14H), 8.9 (s, 1H) and 10.75 (s, 1H).
TLC analysis was carried out using the solvent system: chloroform:MeOH:acetic acid: 45:2:1, v/v/v.
* All the amino acid hydroxamates were characterized by ES-MS.
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to dryness. The residue was dissolved in ethyl acetate
(20 mL) washed with 5% HCl (3×10 mL) and brine (20
mL). The organic layer was dried over anhydrous
Na2SO4, evaporated in vacuo and trituration with pet.
ether gave the product as a white crystalline solid.
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